# Bayzed Health Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bayzed-health-group

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.bayzedhealthcare.com
- Total disclosed funding: $27M
- Latest round: Series A (Jul 1, 2023)
- Investors on record: 3

## About

Based in the Cayman Islands, Bayzed Health Group Inc focuses on developing advanced medical solutions that enhance the prevention and treatment of various health conditions through state-of-the-art medical technologies.Bayzed Health Group Inc, founded in 2017 and headquartered in Beijing, China, specializes in medical technology development aimed at improving patient outcomes. The company has successfully completed 2 deals, with its most recent significant funding being a Series A round in June 2025, raising CNY 192.8 mn from investors including Baihui Investment Fund, Huaxin Capital, and Lucion Venture Capital. The company's current valuation stands at CNY 1,692.8 mn.Bayzed Health Group Inc specializes in the development and provision of advanced medical solutions aimed at precise prevention and treatment of various health conditions. The company’s core offerings focus on innovative medical technologies and therapeutic services designed to enhance patient outcomes across multiple healthcare sectors. These products address specific health challenges faced by a diverse client base, including hospitals, clinics, and healthcare practitioners, who utilize these solutions in clinical settings. The company's solutions are widely implemented in major markets, including Asia and Europe, tailored to meet the unique healthcare needs of these regions. By prioritizing efficacy and precision, Bayzed Health Group Inc positions itself as a key player in the medical technology landscape, ensuring that healthcare providers have access to the tools necessary for effective patient care.The revenue model of Bayzed Health Group Inc is structured around both direct-to-consumer and B2B transactions, catering to healthcare providers and institutions. The company engages in partnerships with hospitals and clinics, offering subscription-based services for its medical technologies, which ensures ongoing access to the latest innovations and support. Revenue is generated through the sale of its flagship products, accompanied by comprehensive service agreements that enhance value for clients. Additionally, the company implements a pricing structure that reflects the complexity and specialized nature of its offerings, ensuring that healthcare providers can effectively integrate these solutions into their existing workflows. Bayzed Health Group Inc's ability to generate consistent revenue is supported by its commitment to delivering high-quality medical solutions that address critical health needs.Bayzed Health Group Inc plans to expand its product offerings by launching new medical technologies designed for enhanced patient care in the upcoming months. The company is targeting expansion into new markets, particularly in Europe and Southeast Asia by the end of 2025. The recent Series A funding round, which raised CNY 192.8 mn, will be utilized to support these initiatives, including research and development for upcoming products and establishing a stronger market presence.

## Funding rounds

- Series A, Jul 1, 2023, $27M — Shandong High-tech Investment Corporation, Huaxin Capital, Baihui Investment Fund

## Investors

- Shandong High-tech Investment Corporation (https://capitalatlas.ai/funds/shandong-high-tech-investment-corporation) — Series A
- Huaxin Capital — Series A
- Baihui Investment Fund — Series A